Format

Send to

Choose Destination
Neurosci J. 2013;2013:679389. doi: 10.1155/2013/679389. Epub 2013 Feb 7.

rTMS as a Treatment of Alzheimer's Disease with and without Comorbidity of Depression: A Review.

Author information

1
Department of Electrical and Computer Engineering, University of Manitoba, Winnipeg, MB, Canada R3T 5V6 ; Graduate Program in Biomedical Engineering, Faculty of Engineering, University of Manitoba, Winnipeg, MB, Canada R3T 5V6.
2
Department of Electrical and Computer Engineering, University of Manitoba, Winnipeg, MB, Canada R3T 5V6.
3
Department of Electrical and Computer Engineering, University of Manitoba, Winnipeg, MB, Canada R3T 5V6 ; Graduate Program in Biomedical Engineering, Faculty of Engineering, University of Manitoba, Winnipeg, MB, Canada R3T 5V6 ; Riverview Health Center, 1 Morley Avenue, Winnipeg, MB, Canada R3L 2P4.

Abstract

With an ever-increasing population of Alzheimer's disease (AD) patients worldwide, a noninvasive treatment for AD is needed. In this paper, the application of repetitive transcranial magnetic stimulus (rTMS) as a treatment for patients with probable AD is compared to the application of rTMS as a treatment for depression. Comorbidity of depression and dementia is discussed, as well as possible links between the two diseases. The possible confounding antidepressant effects of rTMS on cognitive improvements in AD patients are discussed.

Supplemental Content

Full text links

Icon for Hindawi Limited Icon for PubMed Central
Loading ...
Support Center